EFFECTS OF SEMAGLUTIDE ON CHRONIC KIDNEY DISEASE OUTCOMES: A POST HOC POOLED ANALYSIS FROM THE SUSTAIN 6 AND PIONEER 6 TRIALS

被引：0
|
作者：
Tuttle, Katherine
Cherney, David
Hadjadj, Samy
Idorn, Thomas
Mosenzon, Ofri
Perkovic, Vlado
Rasmussen, Soren
Wolthers, Benjamin
Bain, Stephen C.
机构：
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO051
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [41] The effect of once-weekly semaglutide on MACE, blood pressure and lipids by race and ethnicity: a SUSTAIN 6 post hoc analysis
    Bain, S. C.
    Desouza, C. V.
    Gondolf, T.
    Hansen, T.
    Holst, I.
    Rea, R. R.
    Seufert, J.
    DIABETOLOGIA, 2019, 62 : S365 - S365
  • [42] Effect of once-weekly semaglutide on insulin use in subjects with type 2 diabetes: a post hoc analysis of SUSTAIN 6
    Seufert, J.
    Desouza, C.
    Kirk, A. R.
    Lawson, J.
    Lingvay, I.
    Sondergaard, A. L.
    Bain, S. C.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 251 - 252
  • [43] Neutrophil-to-lymphocyte ratio predicts cardiovascular events in patients with type 2 diabetes: post hoc analysis of SUSTAIN 6 and PIONEER 6
    Verma, S.
    Husain, M.
    Madsen, C.
    Leiter, L. A.
    Rajan, S.
    Vilsboll, T.
    Rasmussen, S.
    Libby, P.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2479 - 2479
  • [44] Neutrophil-to-lymphocyte ratio predicts cardiovascular events in patients with type 2 diabetes: post hoc analysis of SUSTAIN 6 and PIONEER 6
    Verma, S.
    Husain, M.
    Madsen, C. M.
    Leiter, L. A.
    Rajan, S.
    Vilsboll, T.
    Rasmussen, S.
    Libby, P.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 253 - 254
  • [45] Efficacy and safety of semaglutide in subjects with type 2 diabetes by race and ethnicity: a post hoc analysis of the SUSTAIN trials
    Desouza, C.
    Garg, S.
    Cariou, B.
    Furberg, J. K.
    Navarria, A.
    Nayak, G.
    Fonseca, V.
    DIABETOLOGIA, 2018, 61 : S369 - S370
  • [46] Semaglutide Improves eGFR Slope vs. Placebo Regardless of Baseline HbA1c and Blood Pressure in People With Type 2 Diabetes: A Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
    Cherney, David
    Bosch-Traberg, Heidrun
    Hadjadj, Samy
    Kuhlman, Anja B.
    Rasmussen, Soren
    Tuttle, Katherine R.
    Heerspink, Hiddo J. L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 675 - 675
  • [47] EFFECTS OF APABETALONE (RVX-208) ON SERUM ALBUMIN IN SUBJECTS WITH CVD, DIABETES AND CHRONIC KIDNEY DISEASE; A POST-HOC ANALYSIS OF THE ASSURE AND SUSTAIN CLINICAL TRIALS
    Kulikowski, Ewelina
    Halliday, Christopher
    Lebioda, Ken
    Johansson, Jan
    Sweeney, Mike
    Kalantar-Zadeh, Kam
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 264 - 264
  • [48] Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
    Shaman, Ahmed M.
    Bain, Stephen C.
    Bakris, George L.
    Buse, John B.
    Idorn, Thomas
    Mahaffey, Kenneth W.
    Mann, Johannes F. E.
    Nauck, Michael A.
    Rasmussen, Soren
    Rossing, Peter
    Wolthers, Benjamin
    Zinman, Bernard
    Perkovic, Vlado
    CIRCULATION, 2022, 145 (08) : 575 - 585
  • [49] Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis
    Michael Lioudis
    Xiaolei Zhou
    Eric Davenport
    Sasikiran Nunna
    Holly B. Krasa
    Dorothee Oberdhan
    Ancilla W. Fernandes
    BMC Nephrology, 24
  • [50] Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis
    Lioudis, Michael
    Zhou, Xiaolei
    Davenport, Eric
    Nunna, Sasikiran
    Krasa, Holly B. B.
    Oberdhan, Dorothee
    Fernandes, Ancilla W. W.
    BMC NEPHROLOGY, 2023, 24 (01)
12345